← All trials
NCT05180695
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 15, 2022
- Primary completion
- Jan 31, 2025
- Completion date
- Jul 31, 2025
- First posted
- Jan 6, 2022
- Last posted
- May 11, 2022
- Enrollment
- 58
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Centre Leon BerardLead sponsor
- National Cancer Institute, FranceCollaborator
- NovartisCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.